The companies will work together for development and commercialization of Novosis rhBMP-2 bone growth materials and other solutions for the U.S. and Canada.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more